May 31, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
| Re: | Gain Therapeutics, Inc. |
Registration Statement on Form S-3, as amended
File No. 333-265061
Acceleration Request
| Requested Date: | June 1, 2022 |
| Requested Time: | 4:00 PM Eastern Daylight Time |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-265061) (as amended, the “Registration Statement”) to become effective on Wednesday, June 1, 2022 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Courtney T. Thorne of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Courtney T. Thorne of Cooley LLP, counsel to the Registrant, at (617) 937-2318.
| Very truly yours, | ||
| Gain Therapeutics, Inc. | ||
| By: | /s/ Eric I. Richman | |
| Eric I. Richman | ||
| Chief Executive Officer | ||
cc: Courtney T. Thorne, Cooley LLP
